Guerbet SA (EPA:GBT)
11.14
+1.04 (10.30%)
Apr 24, 2026, 12:11 PM CET
Guerbet Market Cap
Guerbet has a market cap or net worth of €127.41 million as of April 24, 2026. Its market cap has decreased by -48.89% in one year.
Market Cap
127.41M
Enterprise Value
446.19M
Revenue
798.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
€11.14
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has decreased from 142.85M to 127.41M, a decrease of -10.80%. That is a compound annual growth rate of -0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 127.41M | -29.29% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 244.66M |
| Median Technologies | 186.33M |
| Carvolix | 182.47M |
| Diagnostic Medical Systems | 34.96M |
| Implanet | 30.49M |
| Theraclion | 28.71M |
| Novacyt | 26.88M |
| Ikonisys | 22.50M |